Eclipse’ US$31.4 Million Series B Investment in Capstan Medical

Latham & Watkins advises Eclipse on investment in Capstan Medical.Capstan Medical, a developer of minimally invasive technology to address heart valve disease, closed an oversubscribed US$31.4…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here